Literature DB >> 3389041

Which factors predict the results of pituitary surgery in acromegaly?

W J Oyen1, G F Pieters, E Meijer, J v Laarhoven, A G Smals, P W Kloppenborg.   

Abstract

Thirty-one patients with acromegaly who underwent pituitary surgery were investigated for possible predictive factors of the surgical outcome. The patients were divided into two groups: those whose GH levels normalized (less than 5 micrograms/l) after operation, group A (N = 18), and those whose GH levels remained elevated, group B (N = 13). There were no differences in age, sex distribution and sellar volume between both groups. There was a tendency to a higher incidence of supra-sellar extension of the pituitary tumor in group B (P less than 0.10). The basal GH levels in group A (38 +/- 5 micrograms/l) before operation were significantly lower than in group B (100 +/- 22 micrograms/l, P less than 0.002). Somatomedin C levels after the operation were significantly lower in group A than in group B (P less than 0.05) and were more often in the normal range (P less than 0.05). No differences were found in the occurrence of paradoxical GH responses to TRH and/or to GnRH between the groups and neither were there any differences in GH responses to GHRH and to bromocriptine between the groups. The sensitivity to SRIH tended to be higher in group A. After operation, the paradoxical GH response to TRH disappeared in 7 out of 10 patients and to GnRH in 2 out of 5 patients of group A, whereas in group B this anomaly persisted in all 9 after TRH and all 3 patients after GnRH. Hypopituitarism developed in only 5 out of the 31 patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389041     DOI: 10.1530/acta.0.1170491

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Does SMS 201-995 normalize growth hormone secretion in acromegaly? GH day profiles and GH concentrations after oral glucose loading.

Authors:  P A van Liessum; G F Pieters; A G Smals; L M Swinkels; T J Benraad; P W Kloppenborg
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

Review 2.  Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results.

Authors:  Pedro Carvalho; Eva Lau; Davide Carvalho
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

Review 3.  Acromegaly. Recognition and treatment.

Authors:  C A Jaffe; A L Barkan
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

4.  Acromegaly: role of surgery in the therapeutic armamentarium.

Authors:  Gerardo Guinto; Miguel Abdo; Erick Zepeda; Norma Aréchiga; Moisés Mercado
Journal:  Int J Endocrinol       Date:  2012-11-12       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.